Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - GROSS PROFIT
Gross Profit MBRX - Moleculin Biotech, Inc.
-127 K
LAST VALUE
30.11%
2 YEAR CAGR
-13.31%
5 YEAR CAGR
0.00%
10 YEAR CAGR